Clinical trial INCAGN1876-201
A Phase 1/2 Study Exploring the Safety, Tolerability, and Efficacy of INCAGN01876 in Combination With Immune Therapies in Subjects With Advanced or Metastatic Malignancies
Cancers | |
---|---|
Organ | Multiple |
Trial status | Trial closed |
Investigator | |
Trial type |
Interventional with experimental drug
|
Phase | Trial phase 1 |
Academic trial | Non |
Sponsor | Incyte Corporate |
EudraCT Identifier | 2016-004989-25 |
ClinicalTrials.gov | https://clinicaltrials.gov/ct2/show/NCT03126110 |
Inclusion criteria | second line RECIST 1.1 Biopsy |
Last update |